Published May 12, 2022 | Version 1

Risk of bias assessments for the Cochrane review 'SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19'

Description

Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review: SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19.

Notes

funded by the Federal Ministry of Education and Research, Germany (NaFoUniMedCovid19, funding number: 01KX2021; part of the project "COVIM")

Files

Files (725.9 kB)

Name Size Download all
md5:bbd6088c939400c57bc13274e185d2b4
725.9 kB Download